
“The number of people who experience the devastating effects of preventable infectious diseases like measles, diphtheria, and whooping cough is at an all-time low," according to the Centers for Disease Control and Prevention (CDC).
“The number of people who experience the devastating effects of preventable infectious diseases like measles, diphtheria, and whooping cough is at an all-time low," according to the Centers for Disease Control and Prevention (CDC).
The probability of a measles epidemic occurring in Texas increases as the number of children exempt from receiving the measles vaccine continues to grow.
A trio of speakers addressed the global problem of antibiotic resistance and how the problem is especially vexing in Africa, Asia, and Latin America, at the annual conference of the Infectious Diseases Society of America in New Orleans, Louisiana.
During ID Week, Robert Read, MD, from University Hospital Southampton in Southampton, UK, discussed how a better understanding of meningococcal disease has led to more effective treatment strategies.
At the annual meeting of the Infectious Diseases Society of America in New Orleans, Louisiana, Judith Currier, MD, from the University of California, Los Angeles, discussed the many challenges that HIV-positive individuals face as they live longer lives.
Zika has reached Australia and authorities are taking preventive measures to prevent a large-scale outbreak.
Review authors discuss current knowledge regarding psychobiotics and identify questions for future research.
Doctors at the Children’s Hospital Colorado have published their research on a new approach to antibiotic stewardship, with promising reductions in antibiotic use and rates of Clostridium difficile.
A symposium at the annual meeting of the Infectious Diseases Society of America in New Orleans, Louisiana, highlighted initiatives designed to curb the spread of antibiotic resistance.
Speakers at the Infectious Diseases Society of America annual conference plenary symposium in New Orleans, Louisiana, discuss past successes, current challenges, and future efforts regarding infectious disease.
Zika has been around for a long time, with the first report dating back to 1947. Until 2007, only 14 cases had been reported. Subsequently, there have been three outbreaks, culminating with its arrival in the Americas in the 2015 epidemic in Brazil.
At the Infectious Diseases Society of America Meeting, in New Orleans, Louisiana, Octavio Ramilo, MD, Nationwide Children’s Hospital, Columbus, Ohio, gave a lecture on advancements being made when it comes to host response and pathogenesis of respiratory syncytial virus.
The nation’s top public health officials believes the disease is destined to spread across the United States in the coming months.
Thirty years after the 1980s AIDS crisis, researchers have proven that Gaétan Dugas, known as Patient Zero, was, in fact, not the first AIDS case.
Vaccines are generally quite safe, but a recent study of BCG, DTP, and MCV raises concerns that warrant further exploration.
Despite public outcry, experts agree that vector-control methods are still the most effective ways to fight the spread of the Zika virus.
Researchers from Sweden’s Linköping University discover the pathway that leads to deadly infections in people co-infected with HIV and TB.
New cases of Zika are impacting Florida’s “Little Haiti” neighborhood.
The CDC Foundation and the Florida Department of Health have announced that the the Pfizer Foundation has donated millions to improve Zika response efforts.
The Georgia HCV Elimination Program, the first of its kind, is being heralded as a model for other countries that face a high rate of HCV infection.
With social media serving as a news source to so many, researchers from the Medical College of Wisconsin and the Tulane University School of Medicine studied how Facebook users are talking about the Zika virus.
During the 2016 HIV Research and Prevention (HIVR4P) meeting in Chicago, researchers conducting trials to assess the safety and efficacy of the dapivirine vaginal ring announced several key findings and insights of the ASPIRE study, known as MTN-020.
The Centers for Disease Control and Prevention reported a rise in STDs and a dent in preventive services in their 2015 Sexually Transmitted Disease Surveillance report.
The United Nations Children’s Fund (UNICEF) has partnered with six vaccine makers and the Global Alliance for Vaccines and Immunization (GAVI) to offer 450 million doses of an inexpensive pentavalent vaccine for children.
As the flu hits New Mexico, hundreds are reporting symptoms, while infection has only been lab-confirmed in two cases.
Health leaders call for manufacturers to consider the customer when developing diagnostic tests and discuss the need to develop direct-from-specimen tests to characterize pathogens.
The US Food and Drug Administration has approved Merck’s Zinplava, a monoclonal antibody that will reduce recurrence of Clostridium difficile in high risk patients.
Experts in clinical diagnostics and tracking food-borne outbreaks discuss using culture-independent diagnostic tests (CIDTs) as well as how the use of CIDTs is currently working in Colorado.
The first influenza cases of the 2016-2017 season were reported by the Minnesota Department of Health, a reminder for state residents to receive influenza vaccination.
New studies on the Zika virus have revealed how long the virus may stay in the vaginal tract, as UK researchers have mapped the first complete Zika virus genome derived from semen.